Ranbaxy Labs Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RANBAXY LABS LTD, and what generic and branded alternatives to RANBAXY LABS LTD drugs are available?
RANBAXY LABS LTD has twenty-six approved drugs.
There are eight tentative approvals on RANBAXY LABS LTD drugs.
Summary for Ranbaxy Labs Ltd
| US Patents: | 0 |
| Tradenames: | 24 |
| Ingredients: | 22 |
| NDAs: | 26 |
Drugs and US Patents for Ranbaxy Labs Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranbaxy Labs Ltd | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | SOLUTION;ORAL | 090183-002 | Apr 24, 2008 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Ranbaxy Labs Ltd | CETIRIZINE HYDROCHLORIDE | cetirizine hydrochloride | SOLUTION;ORAL | 077472-001 | Jun 18, 2008 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Ranbaxy Labs Ltd | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | nitrofurantoin; nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 076951-001 | Mar 30, 2005 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
